Treatment of chronic viral hepatitis C (HCV) with BRT, EPT with using Transfer Factors (TF)
AUTHORS : Parfenova N.V. | Eliseeva O. I.
RELEVANT UNIVERSITIES : LLC “Eliseeva Methodological Center”, Moscow, Russia
YEAR : 2007
As you know, viral hepatitis C (HCV) belongs to one of the most common groups of human viral diseases, united by the syndrome of primary liver damage.
The hepatitis C virus contains a positive single-stranded RNA consisting of 10 thousand bases encoding more than 30 thousand amino acids. In the human body,
the virus multiplies in the cells of the liver, blood and spreads to all cells. The hepatitis C virus is a serious public health problem due to the high incidence of
chronic forms in persons with acute hepatitis. The source of infection are patients with acute and chronic forms and, most dangerous, asymptomatic virus carriers.